In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier system that delivers therapeutic antibodies directly to target antigens inside cancer cells.
Polyphenol-conjugated nanocarrier system enhances antibody therapies for breast cancer
